Biotech · Private company

Osmotica Pharmaceutical US LLC

Track this companyFree. Adds Osmotica Pharmaceutical US LLC to your Dealase workspace and tells you when its record changes.

Clinical trials40 recruiting or active

Pipeline programs0None found yet

Disclosed deals0None found yet

Cash runwayNot availablePrivate: no SEC financials

Clinical trials4

A Study to Evaluate the Long-term Safety of Arbaclofen Extended-Release Tablets for Patients With Spasticity Due to MSPHASE3 · COMPLETED · started Apr 3, 2018ClinicalTrials.gov NCT03319732 · fetched Nov 12, 2026
To Assess Effects of Arbaclofen ER Tablets Compared With Placebo on Sperm Parameters in Male Subjects With MSPHASE3 · WITHDRAWN · started Jul 1, 2016ClinicalTrials.gov NCT02869425 · fetched Nov 12, 2026
One Year, Open Label, Dose Escalation Long-term Safety Study in Multiple Sclerosis (MS) Subjects With SpasticityPHASE3 · COMPLETED · started Apr 1, 2013ClinicalTrials.gov NCT01844232 · fetched Nov 12, 2026
Efficacy Study of Arbaclofen to Treat Spasticity in Multiple SclerosisPHASE3 · COMPLETED · started Nov 1, 2012ClinicalTrials.gov NCT01743651 · fetched Nov 12, 2026